New Study Highlights Need for Improved Sepsis Diagnosis and Triage
Cytovale detailed the publication of a new peer-reviewed study that highlights the need for rapid sepsis testing.
Category: Sepsis
Sepsis
Latest
Sepsis
Latest
Cytovale Unveils Commercial Launch of Sepsis Test for Emergency Departments
Cytovale announced the U.S. commercial launch of the IntelliSep sepsis test following FDA 510(k) clearance in December 2022.
Sepsis
Latest
Asep Medical Holdings Clarifies Update on Diagnostic Technologies
At the request of IIROC, Asep Medical Holdings clarified its disclosure regarding its diagnostic and therapeutic technologies.
Sepsis Test Quickly Predicts Infection, Enables Early Treatment
A new test can predict sepsis before blood clots cause organ damage by detecting shifts in blood protein abundance soon after infection.
Read More
Partnership Aims to Combat Hospital Sepsis Using Precision Diagnostics
Prenosis, Inc.is expanding its existing partnership with Roche Diagnostics that will to improve and expedite the clinical recognition of sepsis.
Read More
In The DNA: Shortcut to Identify Pathogens Found
Researchers have developed a new tool that could help provide early warnings of potentially deadly bacterial pathogens which cause sepsis, among other uses.
Read More
Sepsis Detection Furthered with $1.8M NIH Grant
Ke Du, PhD, is developing a microfluidic device to improve detection of drug resistant bacteria in blood, one of the most common pathogens causing sepsis.
Read More
Advances Are Needed for Newborn Sepsis Screening
In screening for sepsis in newborns, there is a need to develop sensitive, and integrated diagnostic strategies to enhance detection.
Read More
Magnolia Medical Releases Steripath Micro Device for Children
Magnolia Medical Technologies, Inc., announces its new Steripath Micro Initial Specimen Diversion Device designed for children’s hospitals.
Read More
NanoDx Collaborates with IBM Research on Sensors for Rapid Diagnostic Testing
NanoDx, Inc., has entered into a licensing agreement with IBM Research for use of its nanoscale sensors for accurate, rapid testing.
Read More
An Algorithm That Predicts Deadly Infections Is Often Flawed
Data from a new study published in JAMA Internal Medicine raises red flags surrounding the practice of relying on proprietary algorithms to warn of dangerous conditions, particularly one used to detect sepsis, reports Wired.
Read More
Study: T2MR Technology Detects Sepsis Faster Than Blood Culture
Findings confirm that T2 Biosystems’ magnetic resonance technology for identification of bloodstream infections provides faster time to detection and shorter hospital stays.
Read More
T2 Biosystems CEO Shares Sepsis Survival Story in New Book
T2 Biosystems CEO John Sperzel has released a book about his personal experience with a bloodstream infection and sepsis, titled “Courage: Powerful Lessons in Leadership, Strength, and the Will to Succeed.”
Read More
Researchers Develop Sensor to Test for Sepsis
The UT Dallas researchers’ sensor is a portable device that monitors a panel of five immune biomarkers using only a single drop of blood plasma, making a sepsis diagnosis available within minutes.
Read More
Turning the Tide on Hospital-Acquired Sepsis with AI
Device manufacturers that unravel technical and regulatory issues will lead the fight.
Read More
Affordable and Fast Clinical Test Can Save Human Lives and Spare At-Risk Population
Sustainable harvesting of limulus amebocyte lysate could save hundreds of thousands of horseshoe crabs per year, while offering life-saving clinical uses for humans.
Read More
T2 Biosystems Receives Multiyear Innovative Technology Contract from Vizient
The contract covers the T2Dx instrument as well as the T2Bacteria and T2Candida panels, which detect sepsis-causing bacterial and fungal pathogens directly from whole blood.
Read MoreT2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer
Sperzel succeeds John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read More